<?xml version="1.0" encoding="UTF-8"?>
<p id="p0095">The products of the LPO extracellular oxidative complex is part of the human natural protective system of central airways against pathogen threats (
 <xref rid="bib20" ref-type="bibr">Day, 2020</xref>; 
 <xref rid="bib2" ref-type="bibr">Alaxia, 2020</xref>; 
 <xref rid="bib16" ref-type="bibr">Cegolon et al., 2014</xref>; 
 <xref rid="bib14" ref-type="bibr">Cegolon, 2020</xref>). Due to the need of maximizing gas exchange, alveolar epithelial cells cannot contain strong protective structures. The latter cells are fragile and vulnerable to infectious agents, as shown by the diffuse alveolar damage discovered in two patients undergoing surgical resections for lung adenocarcinoma, later discovered to be affected also by COVID-19 pneumonia (
 <xref rid="bib71" ref-type="bibr">Tian et al., 2020</xref>). Bronchi were not reported to be as vulnerable as alveoli in the same study (
 <xref rid="bib71" ref-type="bibr">Tian et al., 2020</xref>).
</p>
